Compounded semaglutide isnt FDA-approved and hasnt been through the same testing, but it can still be appropriate when prescribed for a specific medical need and prepared by a reputable compounding pharmacy
Weight Loss Comparison: Injectable Semaglutide (Wegovy 2.4 mg weekly): Average weight loss: 14.9% of body weight Duration: 68 weeks Patients losing 5%+: 86.4% Patients losing 10%+: 69.1% Patients losing 15%+: 50.5% Injectable Tirzepatide (Zepbound 15 mg weekly): Average weight loss: 22.5% of body weight Duration: 72 weeks Patients losing 5%+: 96% Patients losing 10%+: 89% Patients losing 15%+: 78% Patients losing 20%+: 63% Oral Semaglutide (Rybelsus 14 mg daily): Average weight loss: 3-5% of body weight Duration: 26-52 weeks depending on study Patients losing 5%+: Approximately 30-40% Patients losing 10%+: Less than 10% Patients losing 15%+: Rare Real-World Weight Loss Examples: Starting Weight: 250 pounds Starting Weight: 200 pounds Why Such a Big Difference
USA 103 , 1514815153 (2006)
Thus, we conclude that post-stroke weight loss has minimal/no effect on stroke recovery
Focusing on FDA-approved medications In May 2025, Weight Watchers confirmed that it would not be offering compounded semaglutide prescriptions
Some formulas also include ingredients like niacinamide, vitamin C, licorice extract, aloe vera, glycerin, or hyaluronic acid